Final data from Dimerix’s PARASOL collaboration reinforce proteinuria-based endpoints in its phase III ACTION3 trial of lead ...
FaithTime, a Christian app developer for Gen Z, today announced an expansion of its AI-powered platform. The update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback